Antitumor immunity augments the therapeutic effects of p53 activation on acute myeloid leukemia
Yasutaka Hayashi(The University of Tokyo), Toshio Kitamura(The University of Tokyo)
Cited by 53
Related Papers
Identification and Characterization of a Constitutively Active STAT5 Mutant That Promotes Cell Proliferation
|Molecular and Cellular Biology|1998|413
Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation
|The Journal of Experimental Medicine|2018|159
Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis
|Nature Communications|2018|122
Discrimination of Dormant and Active Hematopoietic Stem Cells by G0 Marker Reveals Dormancy Regulation by Cytoplasmic Calcium
|Cell Reports|2019|47
Eliminating chronic myeloid leukemia stem cells by IRAK1/4 inhibitors
|Nature Communications|2022|24